Similar articles for PMID: 28332219

Year	Number of Results
2001	1
2006	2
2010	3
2011	6
2012	4
2013	9
2014	11
2015	16
2016	29
2017	28
2018	32
2019	24
2020	19
2021	17
2022	17
2023	4
2024	0

1

Targeting Immunotherapy to the Tumor Microenvironment.

Dougan M, Dougan SK. Dougan M, et al. J Cell Biochem. 2017 Oct;118(10):3049-3054. doi: 10.1002/jcb.26005. Epub 2017 May 15. J Cell Biochem. 2017. PMID: 28332219 Review.

2

Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment.

Kanapathipillai M, Brock A, Ingber DE. Kanapathipillai M, et al. Adv Drug Deliv Rev. 2014 Dec 15;79-80:107-18. doi: 10.1016/j.addr.2014.05.005. Epub 2014 May 9. Adv Drug Deliv Rev. 2014. PMID: 24819216 Review.

3

Nanoparticles for tumor immunotherapy.

Zang X, Zhao X, Hu H, Qiao M, Deng Y, Chen D. Zang X, et al. Eur J Pharm Biopharm. 2017 Jun;115:243-256. doi: 10.1016/j.ejpb.2017.03.013. Epub 2017 Mar 18. Eur J Pharm Biopharm. 2017. PMID: 28323111 Review.

4

Editorial: Targeting tumor microenvironment heterogeneity.

Hida K, Ishii G. Hida K, et al. Adv Drug Deliv Rev. 2016 Apr 1;99(Pt B):139. doi: 10.1016/j.addr.2016.03.004. Adv Drug Deliv Rev. 2016. PMID: 27018072 No abstract available.

5

Exposing the tumor microenvironment: how gold nanoparticles enhance and refine drug delivery.

Tamarkin L, I Kingston DG. Tamarkin L, et al. Ther Deliv. 2017 Jun;8(6):363-366. doi: 10.4155/tde-2016-0095. Ther Deliv. 2017. PMID: 28530147 Free article. Review. No abstract available.

6

Nanotherapy Targeting the Tumor Microenvironment.

Gong BS, Wang R, Xu HX, Miao MY, Yao ZZ. Gong BS, et al. Curr Cancer Drug Targets. 2019;19(7):525-533. doi: 10.2174/1568009619666181220103714. Curr Cancer Drug Targets. 2019. PMID: 30569855 Review.

7

Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles.

Niu Y, Zhu J, Li Y, Shi H, Gong Y, Li R, Huo Q, Ma T, Liu Y. Niu Y, et al. J Control Release. 2018 May 10;277:35-47. doi: 10.1016/j.jconrel.2018.03.012. Epub 2018 Mar 12. J Control Release. 2018. PMID: 29545106 Review.

8

pH-sensitive drug-delivery systems for tumor targeting.

He X, Li J, An S, Jiang C. He X, et al. Ther Deliv. 2013 Dec;4(12):1499-510. doi: 10.4155/tde.13.120. Ther Deliv. 2013. PMID: 24304248 Review.

9

Novel mechanisms and approaches in the medical therapy of solid cancers.

Awada G, Kourie HR, Awada AH. Awada G, et al. Discov Med. 2015 Jul-Aug;20(108):33-41. Discov Med. 2015. PMID: 26321085 Free article. Review.

10

Targeting the premetastatic niche: epigenetic therapies in the spotlight.

Low V, Blenis J, Gomes AP. Low V, et al. Signal Transduct Target Ther. 2020 May 11;5(1):68. doi: 10.1038/s41392-020-0165-3. Signal Transduct Target Ther. 2020. PMID: 32390001 Free PMC article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

190 results

Results by year